Intercept and OvaScience file for IPOs to progress pipelines
This article was originally published in Scrip
Executive Summary
Two US biotechnology companies in the past week made it widely known that they intend to go to market in initial public offerings in the near future - Intercept Pharmaceuticals and OvaScience.